TWINLOGIC STRATEGIES, LLP

Lobbying for ASSOCIATION FOR ACCESSIBLE MEDICINES · Trade association for generics and biosimilars

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $30,000.00 income · posted Apr 20, 2026

Bills named in this filing 2

S 1096
Preserve Access to Affordable Generics and Biosimilars Act
S 1041
Affordable Prescriptions for Patients Act

Lobbying activity 1

Issues related to patents and generic drugs Monitor S. 1096 - patent settlements Issues relating to review of pharmaceutical patents in inter partes reviews Issues relating to the Patent Trial and Appeal Board Patent thickets - S. 1041 Skinny labeling issues Monitor issues relating to the Patent Eligibility Restoration Act Monitor issues relating to the PREVAIL Act

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.